These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23689467)

  • 1. The role of the serum vitamin D binding protein in the actions of the vitamin D analog eldecalcitol (ED-71) on bone and mineral metabolism.
    Brown AJ; Zhang F; Cooke NE; Ritter CS
    Calcif Tissue Int; 2013 Aug; 93(2):163-71. PubMed ID: 23689467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
    Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
    J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
    Kubodera N; Tsuji N; Uchiyama Y; Endo K
    J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolism.
    Brown AJ; Ritter CS
    Calcif Tissue Int; 2011 Nov; 89(5):372-8. PubMed ID: 21912832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
    Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
    Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Smith SY; Doyle N; Boyer M; Chouinard L; Saito H
    Bone; 2013 Nov; 57(1):116-22. PubMed ID: 23774444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism.
    Ritter CS; Brown AJ
    J Cell Biochem; 2011 May; 112(5):1348-52. PubMed ID: 21337382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo.
    Saito H; Harada S
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():189-96. PubMed ID: 24291401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized rats.
    de Freitas PH; Hasegawa T; Takeda S; Sasaki M; Tabata C; Oda K; Li M; Saito H; Amizuka N
    Bone; 2011 Sep; 49(3):335-42. PubMed ID: 21664310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo.
    Harada S; Takeda S; Uno A; Takahashi F; Saito H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):281-3. PubMed ID: 20398764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
    Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
    Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eldecalcitol reduces osteoporotic fractures by unique mechanisms.
    Kondo S; Takano T; Ono Y; Saito H; Matsumoto T
    J Steroid Biochem Mol Biol; 2015 Apr; 148():232-8. PubMed ID: 25625663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
    Sugimoto M; Futaki N; Harada M; Kaku S
    Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
    Matsumoto T; Takano T; Yamakido S; Takahashi F; Tsuji N
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):261-4. PubMed ID: 20298784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats.
    Peleg S; Uskokovic M; Ahene A; Vickery B; Avnur Z
    Endocrinology; 2002 May; 143(5):1625-36. PubMed ID: 11956143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.